Inclusion Criteria:
Age [≥ 18]
Indications of breast reconstruction: histologically confirmed breast cancer, precancerous lesions (DCIS, LCIS), mutation carrier with increased breast cancer risk, strong family history (lifetime risk > 15%)
The patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1)
Patient information has been provided and all written consents of the patient are available
Exclusion Criteria:
Metastatic breast cancer
Patient with known contraindications against mesh-assisted or plastic-reconstructive breast surgery according to the instruction for use
Patient is kept in an institution under judicial or official orders (MPG §20.3)
Participate in another operative clinical trial, if it relates to the area of reconstructive breast surgery and/or influences the primary endpoint of the clinical trial
